bromopyruvic acid glutathione Drug metabolizing enzymes and their inhibitors' role in cancer resistance 3-Bromopyruvate overcomes cetuximab resistance in
3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy Tumor Energy Metabolism and Potential of 3 Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment Glutathione Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation PMC Anticancer agent 3 bromopyruvic acid forms a conjugate with glutathione ScienceDirect
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



